Getting started with in-house development: storyboarding Blog Post
Learn key storyboarding best practices to optimize your in-house mobile app development & effectively communicate product value.
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States Publication
Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou Hemorrhagic cystitis (HC) caused by viral infections such as BK virus, cytomegalovirus, and/or adenovirus after allogeneic hematopoietic stem cell transplantation (allo-HCT) causes morbidity and mortality,...
Health Canada PRCI Guiding Principles and Observations Blog Post
Health Canada released guidance on March 12, 2019 pertaining to its Public Release of Clinical Information (PRCI) initiative. Health Canada’s objective with this initiative is to make anonymized clinical information in drug submissions and medical device applications publicly available for...
Overcome Research Hurdles: Expert Guidance for Complex Generic Drug Development White Paper
Do expensive bioequivalence studies stall your generic drug approval? Learn how you can streamline complex generic drug development with our white paper.
7 Things to Know About the China Pharmaceutical Industry Blog Post
China is the second largest pharmaceutical market in the world. Demand is likely to increase as the government introduces reforms to improve the country’s health care system. These changes are helping multinational drug makers tap into the Chinese pharmaceutical market....
Patient Engagement and Patient Centricity Series Part II: Types of Patient Advocates Blog Post
Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia, award-winning health advocate and patient engagement champion, for a discussion around patient engagement and patient centricity. Their discussion was moderated by Darshan Kulkarni of the...
A Best Practice Framework for Applying PBPK Modeling to Pediatric Drug Development On-Demand Webinar
Pediatric PBPK models have broad application in the drug development process and are being used increasingly to optimise and replace clinical studies. However, the approach has yet to become fully integrated in regulatory submissions. Emerging data support an expanded integration...
Plan to Accelerate Your Time to Drug Submissions On-Demand Webinar
There are common themes driving how quickly you can get from your last database lock (DBL) to submission of your marketing application. Speaking from first-hand experience across more than 50 marketing submissions, Synchrogenix regulatory science experts will demonstrate how, through...
Part 1: What are oligonucleotide therapeutics, and how do they work? On-Demand Webinar
In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including proteins, oligonucleotides, viral vectors, and engineered cells. One area within Complex Biologics experiencing tremendous growth is oligonucleotide therapies— nucleic acid polymers with the potential to...
Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations On-Demand Webinar
In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including proteins, oligonucleotides, viral vectors, and engineered cells. One area within Complex Biologics experiencing tremendous growth is oligonucleotide therapies— nucleic acid polymers with the potential to...
